Stay updated on Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now presents details of the China extension trial of pembrolizumab versus chemotherapy, including eligibility criteria, treatment arms, outcomes, and study locations.SummaryDifference68%

- Check17 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH announcement appears above the page, describing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer’s revision number changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record contents with a basic error screen. This blocks access to the trial information on the page.SummaryDifference19%

Stay in the know with updates to Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial page.